Top Tweets for #PNETS
New Publication on new innovation theranostics for pancreatic neuroendocrine tumors! Be sure to read here: https://t.co/IX37Ws9dyV. Thank you @DrDespina123 for her guidance throughout this process! #weillcornell #nyitcomdo #theranostics #precisiononcology #pNETs @NaturePortfolio
Congrats to #NYITCOM student doctor Christina Bogdani, OMS III, on her first publication in NPJ Precision Oncology! Read more: https://t.co/xIrN9sFeQg
Her article explores cutting-edge innovations in theranostics for pancreatic neuroendocrine tumors

Building on #theranostics for #pNETs—our latest @Nature_NPJ article dives into innovations in #PRRT, SSTR2 antagonists, & alpha emitters. We explore how molecular imaging & targeted radionuclides are reshaping #PrecisionOncology. Read more: https://t.co/lty43vTh5P
@WCMGIcancer

Building on #theranostics for #pNETs—our latest @Nature_NPJ article dives into innovations in #PRRT, SSTR2 antagonists, & alpha emitters. We explore how molecular imaging & targeted radionuclides are reshaping #PrecisionOncology. Read more: https://t.co/lty43vTh5P
@WCMGIcancer

Congratulations, Dr. Siolas @DrDespina123 ! 👏 An exciting and impactful contribution to the field of #theranostics and #PrecisionMedicine. A great read to learn about the advances in the care for patients with pancreatic neuroendocrine tumors! #Oncology #pNETs
🚨 New publication alert! Read my latest #research on #theranostics for pancreatic neuroendocrine tumors, published with @SpringerNature in @Nature_NPJ
📄 https://t.co/lty43vTh5P #Oncology #PRRT #pNETs #PrecisionMedicine @WCMGIcancer @WCMDeptofMed

🚨 New publication alert! Read my latest #research on #theranostics for pancreatic neuroendocrine tumors, published with @SpringerNature in @Nature_NPJ
📄 https://t.co/lty43vTh5P #Oncology #PRRT #pNETs #PrecisionMedicine @WCMGIcancer @WCMDeptofMed


Jennifer Chan, MD, MPH, of @DanaFarber discussed the recent #FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors. #pNETs
https://t.co/7AMArQ6dvS

1%-2% of #pancreatic tumors are #neuroendocrine tumors (#pNETs). Surgery is the only curative treatment, but the disease will recur in many patients. S2104 tests whether adjuvant #chemo extends RFS and OS.
Co-PI: @SyedAAhmad5 @uc_health
https://t.co/KJaHiyAF4v

🌟Congratulations to @DrWilliamHwang @MGHCancerCenter--2025 NETRF Research Award recipient! His focus: Exploring how nerves around pancreatic neuroendocrine tumors impact cancer growth & outcomes.More:https://t.co/9uN62tj9EO
#neuroendocrinecancer #PNETs

#GIonc study in @JofSurgOnc
#LVI in node (-) #pNETs is linked to recurrence:
⬆️ incidence w/ ⬆️tumor size and ⬆️Ki-67 levels
5⃣year #RFS was highest in #LVI (-) pt, making LVI a 🔑 prognostic factor.
🔗: https://t.co/VACaxN7Jnh
@OncoAlert🚨 @FlavioRochaMD
#OncoAlertAF
@yekeduz_emre
@FadiHaddad_MD
@Abdallah81MD
@Erman_Akkus
@Abdallah81MD
@bavilima
@acampsmalea
@DrFMartinelli
@lungoncdoc
@Dr_Ivanoncologo
@orellanauro
@FernandoOnco
@Lucarecco
@HHorinouchi
@ElisaAgostinett
@to_be_elizabeth
@BiagioRicciutMD
@nataliagandur

We're excited to share new developments in #PNETs research, thanks to Dr. Michael Roehrl at Beth Israel Deaconess Medical Center. Supported by NETRF Investigator Award, Dr. Roehrl's study has insights that could reshape how we treat PNETs. https://t.co/fAiIRo1pru

🔍Still looking for an effective preop therapy to downstage #PNETs
PRRT is promising☢️👇🏻
Questions remaining🤨
1⃣Where do response rates from RCT happen?
2⃣Is response enough to move to resectability?
3⃣Patient selection? definitions of resectability needed for PNETs
@OncoThor @spartelli
Are you not convinced of PRRT efficacy for NETs yet? If not, take a look at this. Nonfunctional pancreatic NET, G2, Ki-67 7%, very extensive hepatic and osseous metastases. Status post 4 cycles of PRRT with Lu-177 DOTATATE with no further maintenance therapy. Impressive...

First session of the @RACSurgeons #Endocrinesurgery section is underway, with @DrCNClarke discussing #PNETs @MCWSurgery @mcwsurgonc @NANETS1 @AcademicSurgery #RACS24

Relevance of nodal metatases in #PNETs: 🆕📝by @spartelli @valentinandreas
👥1⃣0⃣0⃣resected NF-PNETs, prospective
🔬Micromets (<5mm) in 38%👉🏻same DFS as N0
‼️No macromet in resected PNET <2cm
⚠️Implications in surveillance protocols
🧐Do micromet LN need resecting?
🔗👇🏻

Proud of my postbac Srujana Yellapragada who gave an amazing talk about her work on #CAFs in #PNETs at the 2024 CCR Fellows and Young Investigator Colloqium @NCIResearchCtr @NCICCR_SurgOnc @NANETS1 @netcancerfound

👇🎯🎯Excellent review on the surgical management of #PNETs including updates on molecular pathways and new clinical trials @NCIResearchCtr @NCICCR_SurgOnc @NANETS1 @TheAAES @CureNETs
Proud to present our latest publication on Surgical Management and Long-Term Evaluation of #Pancreatic Neuroendocrine Tumors! #NET #surgonc 🔗https://t.co/99oBVph4SX @samira_sadowski @AndrewsStephenG @NCI_SurgOncFel @SurgicalClinics

Not all nodal metastases are equal for #PNETs - @valentinandreas @spartelli at #ENETS24
Resected PNETs:
🔬micromets (<5mm) have same DFS as N0
➡️Not all nodal disease is clinically meaningful
⚠️Important info in discussing extent of surgery & LND

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
241.1M followers

Barack Obama 
@barackobama
119.1M followers

Cristiano Ronaldo 
@cristiano
112.5M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.2M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.4M followers

KATY PERRY 
@katyperry
88.8M followers

Taylor Swift 
@taylorswift13
82.7M followers

Lady Gaga 
@ladygaga
74.2M followers

Virat Kohli 
@imvkohli
71.6M followers

Kim Kardashian 
@kimkardashian
70.3M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.5M followers

Neymar Jr 
@neymarjr
64.5M followers

The Ellen Show
@theellenshow
62.4M followers

Selena Gomez 
@selenagomez
61.8M followers

CNN 
@cnn
61.8M followers

X 
@x
60.8M followers




















